239 related articles for article (PubMed ID: 1517881)
1. Sequential dermal microvascular and perivascular changes in the development of scleroderma.
Prescott RJ; Freemont AJ; Jones CJ; Hoyland J; Fielding P
J Pathol; 1992 Mar; 166(3):255-63. PubMed ID: 1517881
[TBL] [Abstract][Full Text] [Related]
2. Vascular damage and lack of angiogenesis in systemic sclerosis skin.
Konttinen YT; Mackiewicz Z; Ruuttila P; Ceponis A; Sukura A; Povilenaite D; Hukkanen M; Virtanen I
Clin Rheumatol; 2003 Sep; 22(3):196-202. PubMed ID: 14505210
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis.
Maurer B; Busch N; Jüngel A; Pileckyte M; Gay RE; Michel BA; Schett G; Gay S; Distler J; Distler O
Circulation; 2009 Dec; 120(23):2367-76. PubMed ID: 19933934
[TBL] [Abstract][Full Text] [Related]
4. Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis.
Manetti M; Milia AF; Guiducci S; Romano E; Matucci-Cerinic M; Ibba-Manneschi L
J Rheumatol; 2011 Feb; 38(2):297-301. PubMed ID: 21078716
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructure of the dermal microvasculature in leprosy.
Turkel SB; Van Hale HM; Rea TH
Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):164-71. PubMed ID: 6889577
[TBL] [Abstract][Full Text] [Related]
6. Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis.
Rajkumar VS; Sundberg C; Abraham DJ; Rubin K; Black CM
Arthritis Rheum; 1999 May; 42(5):930-41. PubMed ID: 10323448
[TBL] [Abstract][Full Text] [Related]
7. Potential benefit of statins for vascular disease in systemic sclerosis.
Kuwana M
Curr Opin Rheumatol; 2006 Nov; 18(6):594-600. PubMed ID: 17053504
[TBL] [Abstract][Full Text] [Related]
8. Hyperplasia of dermal microvascular pericytes in scleroderma.
Helmbold P; Fiedler E; Fischer M; Marsch WCh
J Cutan Pathol; 2004 Jul; 31(6):431-40. PubMed ID: 15186431
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of microvascular endothelial cells from the adult human dermis and from skin biopsies of patients with systemic sclerosis.
Kräling BM; Jimenez SA; Sorger T; Maul GG
Lab Invest; 1994 Nov; 71(5):745-54. PubMed ID: 7967526
[TBL] [Abstract][Full Text] [Related]
10. Does transformation of microvascular endothelial cells into myofibroblasts play a key role in the etiology and pathology of fibrotic disease?
Karasek MA
Med Hypotheses; 2007; 68(3):650-5. PubMed ID: 17045756
[TBL] [Abstract][Full Text] [Related]
11. Microvascular proliferation in congenital vascular malformations of skin and soft tissue.
Meijer-Jorna LB; van der Loos CM; de Boer OJ; van der Horst CM; van der Wal AC
J Clin Pathol; 2007 Jul; 60(7):798-803. PubMed ID: 16816171
[TBL] [Abstract][Full Text] [Related]
12. Dermal dendritic cell population and blood vessels are diminished in the skin of systemic sclerosis patients: relationship with fibrosis degree and disease duration.
de-Sá-Earp AP; do Nascimento AP; Carneiro SC; Porto LC; Monte-Alto-Costa A
Am J Dermatopathol; 2013 Jun; 35(4):438-44. PubMed ID: 23262669
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.
Del Rosso A; Distler O; Milia AF; Emanueli C; Ibba-Manneschi L; Guiducci S; Conforti ML; Generini S; Pignone A; Gay S; Madeddu P; Matucci-Cerinic M
Ann Rheum Dis; 2005 Mar; 64(3):382-7. PubMed ID: 15708892
[TBL] [Abstract][Full Text] [Related]
14. Morphology of delayed-type hypersensitivity reactions in man. II. Ultrastructural alterations affecting the microvasculature and the tissue mast cells.
Dvorak AM; Mihm MC; Dvorak HF
Lab Invest; 1976 Feb; 34(2):179-91. PubMed ID: 1249919
[TBL] [Abstract][Full Text] [Related]
15. Activation of dermal connective tissue in scleroderma.
Kähäri VM
Ann Med; 1993 Dec; 25(6):511-8. PubMed ID: 8292298
[TBL] [Abstract][Full Text] [Related]
16. Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (Scleroderma).
Nguyen VA; Sgonc R; Dietrich H; Wick G
J Autoimmun; 2000 Mar; 14(2):143-9. PubMed ID: 10677245
[TBL] [Abstract][Full Text] [Related]
17. Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy.
Freemont AJ; Hoyland J; Fielding P; Hodson N; Jayson MI
Br J Dermatol; 1992 Jun; 126(6):561-8. PubMed ID: 1610706
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage.
Venneker GT; van den Hoogen FH; Boerbooms AM; Bos JD; Asghar SS
Lab Invest; 1994 Jun; 70(6):830-5. PubMed ID: 7516986
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous lesions of dermatomyositis with supervening fibrosis.
Magro CM; Dyrsen M; Kerns MJ
J Cutan Pathol; 2008 Jan; 35(1):31-9. PubMed ID: 18095992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
